Mylan Tries To Escape Pharmacy's EpiPen Antitrust Suit

By Meghan Kelly · December 15, 2020, 5:46 PM EST

Mylan Pharmaceuticals has urged a Kansas federal judge to drop it from a suit alleging it inflated the price for the emergency allergy medication EpiPen, arguing the retail and online pharmacy...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

In Re: Epipen (Epinephrine Injection, USP) Marketing, Sales Practices and Antitrust Litigation

Case Number

2:17-md-02785

Court

Kansas

Nature of Suit

Personal Inj. Prod. Liability

Date Filed

August 04, 2017

Case Title

KPH Healthcare Services, Inc. v. Mylan N.V. et al

Case Number

2:20-cv-02065

Court

Kansas

Nature of Suit

Anti-Trust

Date Filed

February 14, 2020

Featured Stories

What To Watch For In 1st Paragard Bellwether Trial No Photo Available

Cara Salvatore

Drugmaker Teva is set to face its first bellwether trial starting Tuesday in a multidistrict litigation containing thousands of claims... (more story)

Immigrant Visa Pause Could Test Limits Of Executive Power No Photo Available

Britain Eakin

The Trump administration's indefinite pause on immigrant visas for applicants from 75 countries may test the outer bounds of executive... (more story)

Dispatch From JPM: Fewer Health Deals Don't Dampen Mood No Photo Available

Yeji Jesse Lee

Despite an unusual dearth of big deal announcements, attorneys at the annual J.P. Morgan healthcare conference in San Francisco are st... (more story)